Tylenol Extra Strength
- Product NDC
- 67751-167
- 11-digit product format
- 677510167
- Labeler code
- 67751
- Product ID
- 67751-167_2385e645-881c-5dd8-e063-6394a90adfab
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- ACETAMINOPHEN
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Navajo Manufacturing Company Inc.
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2016-09-22
- Substance
- ACETAMINOPHEN
- Active strength
- 500 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 67751-167 | 67751-167-04 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 67751-167 | 67751-167-03 | D | Discontinued by firm | 2026-10-05 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 67751-167-03 | 1332a3947898… | d4bfe170f9cd… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 67751-167-02 | 1332a3947898… | d4bfe170f9cd… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 67751-167-04 | 1332a3947898… | d4bfe170f9cd… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 67751-167-01 | 1332a3947898… | d4bfe170f9cd… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 67751-167-01 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 67751-167-04 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 67751-167-03 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 67751-167-02 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 67751-167-01 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 67751-167-04 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 67751-167-03 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 67751-167-02 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 67751-167-01 | bd6a592717d7… | 303034d00443… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 67751-167-04 | bd6a592717d7… | 303034d00443… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 67751-167-03 | bd6a592717d7… | 303034d00443… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 67751-167-02 | bd6a592717d7… | 303034d00443… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | 8dfbde2a14a4… | c9ff85d89658… | |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 67751-167-03 | 8dfbde2a14a4… | c9ff85d89658… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded product | product | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 67751-167-03 | e2bbac7714bc… | 27bdfed8d636… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded product | product | 9bebd1f3094a… | 5416666fcb17… | |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 67751-167-03 | 9bebd1f3094a… | 5416666fcb17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tylenol Extra Strength
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 500 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 86b6ac01-3866-4cd8-a1be-9babb6ff311b | Available on FDA.report |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Indexing SPL | Related label |
|---|---|---|---|
| 67751-167-01 | 2024-04-17 | d6a99b39-4b62-a426-e053-dadaa90af4c2 | Tylenol Extra Strength |
| 67751-167-02 | 2024-04-17 | d6a99b39-4b62-a426-e053-dadaa90af4c2 | Tylenol Extra Strength |
| 67751-167-03 | 2024-04-17 | 9d75b9cf-e68d-f424-e053-dadaa90a57ce | Tylenol Extra Strength |
| 67751-167-04 | 2024-04-17 | d6a99b39-4b62-a426-e053-dadaa90af4c2 | Tylenol Extra Strength |
| 67751-167-01 | 2022-01-28 | d6a99b39-4b62-a426-e053-dadaa90af4c2 | Tylenol Extra Strength |
| 67751-167-02 | 2022-01-28 | d6a99b39-4b62-a426-e053-dadaa90af4c2 | Tylenol Extra Strength |
| 67751-167-04 | 2022-01-28 | d6a99b39-4b62-a426-e053-dadaa90af4c2 | Tylenol Extra Strength |
| 67751-167-03 | 2020-01-31 | 9d75b9cf-e68d-f424-e053-dadaa90a57ce | Tylenol Extra Strength |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67751-167-01 | Tylenol Extra Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 6 | |
| 67751-167-01 | Tylenol Extra Strength | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 6 | |
| 67751-167-02 | Tylenol Extra Strength | 4 in 1 POUCH | TABLET, FILM COATED | 4 | 6 | |
| 67751-167-02 | Tylenol Extra Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 6 | |
| 67751-167-04 | Tylenol Extra Strength | 12 in 1 TRAY | TABLET, FILM COATED | 12 | 6 | |
| 67751-167-04 | Tylenol Extra Strength | 1 in 1 POUCH | TABLET, FILM COATED | 1 | 6 | |
| 67751-167-03 | Tylenol Extra Strength | 12 in 1 TRAY | TABLET, FILM COATED | 12 | 2 | |
| 67751-167-03 | Tylenol Extra Strength | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 67751-167 | TYLENOL EXTRA STRENGTH (ACETAMINOPHEN) TABLET, FILM COATED [NAVAJO MANUFACTURING COMPANY INC.] | 6 | Current NDC, Legacy NDC, 6 package rows | 20241004_86b6ac01-3866-4cd8-a1be-9babb6ff311b.zip |
| 67751-167 | TYLENOL EXTRA STRENGTH (ACETAMINOPHEN) TABLET, FILM COATED [NAVAJO MANUFACTURING COMPANY INC.] | 2 | Current NDC, Legacy NDC, 2 package rows | 20240418_65bf1556-f25a-9439-e053-2a91aa0a3194.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PhysiciansCare Non Aspirin Extra Strength | ACETAMINOPHEN | Acme United Corporation | c7006775-bd5b-412f-963d-ce5a158216c5 | 2025-10-31 | Warnings | M013 |
| Pain Reliever | ACETAMINOPHEN | Walgreens | f7aa624b-b00c-4fd3-9965-8e4d2b3eb4ba | 2025-10-31 | Warnings | M013 |
| Extra Strength Acetaminophen | ACETAMINOPHEN | NuCare Pharmaceuticals, Inc. | 41affa1a-5aac-7fc0-e063-6394a90a5557 | 2025-10-30 | Warnings | M013 |
| MAPAP Extra Strength | ACETAMINOPHEN | Major Pharmaceuticals | 34a95450-3f04-4de4-9113-73e7bd5724a0 | 2025-10-29 | Warnings | M013 |
| GOODNOW PAIN RELIEF | ACETAMINOPHEN | Gobrands, Inc | 4d4a78a5-5a88-4f24-b685-c7c6bb5e989e | 2025-10-29 | Warnings | M013 |
| Sanaflu Xtra | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | GRANDALL DISTRIBUTING, LLC | 4af8a566-5251-4d46-8692-87a3a0748334 | 2025-10-28 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Rising Pharma Holdings, Inc. | f8237772-7656-49fb-b1de-f8fcb5fa55ee | 2025-10-28 | Warnings | M013 |
| Enteric Aspirin | ASPIRIN | CHAIN DRUG MARKETING ASSOCIATION INC | a791d664-99fe-4cba-95cf-f49baedde326 | 2025-10-27 | Warnings | M013 |
| DG Health Pain Relief | ACETAMINOPHEN | Dolgencorp Inc | 42f0c87c-7020-4af7-9f6b-3a774137e564 | 2025-10-24 | Warnings | M013 |
| Meijer Childrens Pain and Fever Reducer | ACETAMINOPHEN | MEIJER DISTRIBUTION INC | b416857a-22d5-4504-9bbc-69ab5429654d | 2025-10-24 | Warnings | M013 |
| Children Pain and Fever Reliever | ACETAMINOPHEN | MEIJER DISTRIBUTION INC | 60012b2b-1c73-4b5f-92de-b6794f7b33ab | 2025-10-24 | Warnings | M013 |
| GOODYS Hangover | ASPIRIN AND CAFFEINE | Medtech Products Inc. | 0b0067e0-58b0-4581-aa4b-e398c32c559a | 2025-10-23 | Warnings | M013 |
| GOODYS Extra Strength Headache Mixed Fruit Blast | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Medtech Products Inc. | 6cb758bf-5a50-46bb-96e7-65b810b12de0 | 2025-10-23 | Warnings | M013 |
| Nyt Time Sleep Caps | DIPHENHYDRAMINE HYDROCHLORIDE | DISCOUNT DRUG MART | e3f4d063-921d-4503-89a6-26cc9c46b4c9 | 2025-10-23 | Warnings | M013 |
| Anacin | ASPRIN AND CAFFEINE | Insight Pharmaceuticals LLC | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 2025-10-23 | Warnings | M013 |
| Goodys Back and Body Pain | ACETAMINOPHEN AND ASPRIN | Medtech Products Inc. | 055d0288-61d4-48bc-b91f-6ecc1969beb8 | 2025-10-23 | Warnings | M013 |
| Goodys Cool Orange Headache | ACETAMINOPHEN AND ASPIRIN AND CAFFEINE | Medtech Products Inc. | 31212c97-9975-427e-bc3d-f7125f30299a | 2025-10-23 | Warnings | M013 |
| BC Arthritis | ASPIRIN AND CAFFEINE | Medtech Products Inc. | 3a85be2d-6548-4de5-8109-60e1ca2bfca3 | 2025-10-23 | Warnings | M013 |
| Goodys Extra Strength | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Medtech Products Inc. | d4325b17-23bc-44ac-868d-bb0886853a73 | 2025-10-23 | Warnings | M013 |
| BC | ASPIRIN AND CAFFEINE | Medtech Products Inc. | 226173d4-b6d5-4fe6-b24e-1cc5d1b31c88 | 2025-10-23 | Warnings | M013 |
DailyMed RxNorm Mappings#
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 67751-167-01 | 67751016701 | 1 POUCH in 1 CARTON (67751-167-01) / 2 TABLET, FILM COATED in 1 POUCH | 1 pouch | 2016-09-22 | 0000-00-00 | No | No | Current |
| 67751-167-02 | 67751016702 | 1 POUCH in 1 CARTON (67751-167-02) / 4 TABLET, FILM COATED in 1 POUCH | 1 pouch | 2016-09-22 | 0000-00-00 | No | No | Current |
| 67751-167-03 | 67751016703 | 12 in 1 TRAY | Historical | |||||
| 67751-167-04 | 67751016704 | 12 POUCH in 1 TRAY (67751-167-04) > 1 TABLET, FILM COATED in 1 POUCH | 12 pouch | 2016-09-22 | 0000-00-00 | No | No | Current |